Metraipolis › archive › dc_e0cfcc54c87e
First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42780725
- DOI
- 10.3389/fonc.2026.1871703
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T23:25:33.338Z
- SHA-256 of the archived text
236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7- Stable URL of this page
https://metraipolis.com/documento/dc_e0cfcc54c87e
How to cite
First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725 — Europe PMC (en), https://europepmc.org/article/MED/42780725 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0cfcc54c87e (Metraipolis archive dc_e0cfcc54c87e, sha256 236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7)
BibTeX
@misc{dce0cfcc54c87e,
title = {First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42780725},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0cfcc54c87e; sha256 236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42780725. Agents can read the archived copy with the MCP tool read_document.